Novartis new two-year data with Certican® shows positive outcomes at 24 months in largest liver transplant trial to date

Study`s endpoints met; Certican with reduced exposure tacrolimus provided comparable efficacy with superior renal function maintained from month one to 24 versus control arm [1]  Calcineurin inhibitors ...